Oracle Corporation has entered into a strategic collaboration with M42, a global health leader specializing in technology, artificial intelligence, and genomics, to transform healthcare delivery across the UAE. The partnership will leverage AI, advanced analytics, and genomic data from the Emirati Genome Program to drive proactive healthcare, promote healthy longevity, and enable precision medicine at scale. By integrating this genomic data into Oracle Health's electronic health record system, the initiative aims to provide pharmacogenomic recommendations at the point of care, supporting personalized and data-driven treatment decisions. The collaboration will also deliver nationwide access to a secure, scalable patient portal, enhancing care coordination and patient engagement throughout the UAE.